Why are some COVID cases more severe than others? 'Humanized' mice offer a clue
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?
Dec 18, 2021
0
350
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?
Dec 18, 2021
0
350
An international team of researchers has developed a new approach to pinpoint which proteins in our cells are most critical for increasing sugar absorption after exercise—an important benefit of exercise that can help maintain ...
Dec 10, 2021
0
103
Researchers at Karolinska Institutet, University of Oslo and Oslo University Hospital have developed a new kind of immunotherapy for leukemia. The results of a study published in Nature Biotechnology show that the therapy ...
Dec 6, 2021
0
226
A Ludwig Cancer Research study has devised a highly efficient method to generate large numbers of immune cells specifically engineered to recognize neoantigens—small fragments of randomly mutated proteins that are typically ...
Nov 15, 2021
0
71
RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities. However, because of their structural complexity and relative stability, RNA also has attracted ...
Oct 28, 2021
0
0
Grégoire Courtine doesn't hesitate to use the word "revolutionary" when describing the emerging field of optogenetics—a technology that uses pulses of light to control individual neural activity—and what it could mean ...
Sep 27, 2021
0
81
A team of researchers with biotechnology corporation Genentech Inc., has developed a new way to capture the origins and early adaptive processes that are involved in therapy responses to cancer treatments. In their paper ...
An international research collaboration has identified a new gold standard for detecting cancer mutations using genomic pathology.
Sep 10, 2021
0
62
COVID-19 patients have differing immune responses that lead to disease outcomes ranging from asymptomatic SARS-CoV-2 infection to death. After examining the blood samples from nearly 200 COVID-19 patients, researchers have ...
Sep 6, 2021
0
362
In recent years, scientists have developed monoclonal antibodies—proteins that mimic the body's own immune defenses—that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn's ...
Aug 30, 2021
0
65